The groundbreaking rise of copyright’s flagship product presented a massive opportunity for shareholders , but its patent has lapsed , creating a complex landscape. Alternative versions have entered the market , eroding sales and putting pressure on profit percentages . While leading drug companies maintain a foothold in this sector , the potenti